Primary Care/Hospitalist Topics
RSSArticles
-
Early Trial Results Suggest Many Acute Appendicitis Patients Could Safely Delay or Avoid Surgery
In a study, 70% of patients with appendicitis who were treated with antibiotics avoided surgery at 90 days. This creates possibilities for patients and providers for a common diagnosis in the ED.
-
Study of Epidural Analgesia Stirs Controversy
Several groups stand in strong opposition to a group of researchers’ recent conclusion about possible connection to autism risk.
-
Medical Groups Pool Resources to Promote Behavioral, Mental Health
Collaborative supports physicians trying to overcome barriers to integrating these services into primary practice.
-
Ticagrelor in the Elderly: More Potent Platelet Inhibition Not Always Better
In a study of 14,000 elderly patients with acute myocardial infarction, treatment with ticagrelor was associated with higher risks of bleeding and all-cause death vs. clopidogrel.
-
Pralsetinib Capsules (Gavreto)
Pralsetinib should be prescribed to treat adults with metastatic RET, fusion-positive non-small cell lung cancer.
-
U.S. Obesity Rates on the Rise
News arrives on the heels of several recently published papers that indicate obesity can exacerbate COVID-19.
-
Plasma Biomarker May Indicate When Athletes Can Return to Play After Concussion
A better understanding of these biomarkers may help improve health and safety of athletes.
-
We’d Love to Hear from You!
Please complete our annual reader survey (https://bit.ly/2XYHWdM).
-
The ABCs of CBD: The Fundamentals of Cannabidiol
Cannabidiol (CBD) is one of two major constituents of marijuana and is the non-psychoactive component of cannabis. As its popularity has grown, questions about CBD from patients to their primary care clinicians have increased dramatically. As a patient advocate interpreting the available evidence, the primary care clinician needs to recognize how CBD differs from marijuana, what its clinical utility might be, and what its risks are.
-
Managing Complications of New-Age Cancer Therapy
Cancer patients undergoing treatment are immunocompromised and at high risk for developing early complications leading to critical illness. Compared to complications encountered with conventional chemotherapy, new-generation immunotherapies pose unique diagnostic challenges because their presentation can be vague and nonspecific or can mimic autoimmune diseases.